Nov 29, 2023 8:00 am EST MIRA Pharmaceuticals Announces Ketamir-2's Oral Bioavailability Predicted to be 80%
Nov 21, 2023 10:42 am EST MIRA Pharmaceuticals To Host Shareholder Update Call on Tuesday, December 5, 2023 at 11:30 a.m. Eastern Time